Publications by authors named "Lewis Silver"

Claim this Profile
T
The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.
Jess T Whitson, Katherine I Ochsner, Marlene R Moster, E Kenneth Sullivan, Russell M Andrew, Lewis H Silver

Ophthalmology· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
Eli O Meltzer, Frank C Hampel, Paul H Ratner, David I Bernstein, Lawrence V Larsen, Lewis H Silver

Ann Allergy Asthma Immunol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis.
Lewis H Silver, Adrienne M Woodside, Dawnelle B Montgomery

Surv Ophthalmol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.
Paul H Ratner, Frank C Hampel, Niran J Amar, Julius H van Bavel, Dale Mohar, Lewis H Silver

Ann Allergy Asthma Immunol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.
Harvey B Dubiner, Marla D Sircy, Theresa Landry, Michael V W Bergamini, Lewis H Silver

Clin Ther· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension.
Peter A Netland, Stella M Robertson, E Kenneth Sullivan, Lewis Silver, Michael V W Bergamini

Adv Ther· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.
Mark R Hellberg, Marsha A McLaughlin, Naj A Sharif, Louis DeSantis, Tom R Dean, Lewis Silver

Surv Ophthalmol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
Ronald L Fellman, E Kenneth Sullivan, Marla Ratliff, Lewis H Silver, Jess T Whitson

Ophthalmology· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis